BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 3927348)

  • 1. Separation of the associative and non-associative effects of brain serotonin released by p-chloroamphetamine: dissociable serotoninergic involvement in avoidance learning, pain and motor function.
    Ogren SO; Johansson C
    Psychopharmacology (Berl); 1985; 86(1-2):12-26. PubMed ID: 3927348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Forebrain serotonin and avoidance learning: behavioural and biochemical studies on the acute effect of p-chloroamphetamine on one-way active avoidance learning in the male rat.
    Ogren SO
    Pharmacol Biochem Behav; 1982 Jun; 16(6):881-95. PubMed ID: 7111347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for a role of brain serotonergic neurotransmission in avoidance learning.
    Ogren SO
    Acta Physiol Scand Suppl; 1985; 544():1-71. PubMed ID: 3006431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor involvement in the avoidance learning deficit caused by p-chloroamphetamine-induced serotonin release.
    Ogren SO
    Acta Physiol Scand; 1986 Mar; 126(3):449-62. PubMed ID: 2870606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the avoidance learning deficit induced by the serotonin releasing compound p-chloroamphetamine.
    Ogren SO
    Brain Res Bull; 1986 May; 16(5):645-60. PubMed ID: 3742248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Test-dependent variations in the antinociceptive effect of p-chloroamphetamine-induced release of 5-hydroxytryptamine.
    Ogren SO; Berge OG
    Neuropharmacology; 1984 Aug; 23(8):915-24. PubMed ID: 6237274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of spinal serotonergic pathways in nociception but not in avoidance learning.
    Ogren SO; Berge OG; Johansson C
    Psychopharmacology (Berl); 1985; 87(3):260-5. PubMed ID: 3001802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central serotonin neurones in avoidance learning: interactions with noradrenaline and dopamine neurones.
    Ogren SO
    Pharmacol Biochem Behav; 1985 Jul; 23(1):107-23. PubMed ID: 2994116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin and fear retention in the rat.
    Archer T
    J Comp Physiol Psychol; 1982 Jun; 96(3):491-516. PubMed ID: 7096685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin involvement in aversive conditioning: reversal of the fear retention deficit by long-term p-chloroamphetamine but not p-chlorophenylalanine.
    Archer T; Ogren SO; Ross SB
    Neurosci Lett; 1982 Dec; 34(1):75-82. PubMed ID: 6219302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test-specific effects of the 5-HT reuptake inhibitors alaproclate and zimelidine on pain sensitivity and morphine analgesia.
    Ogren SO; Holm AC
    J Neural Transm; 1980; 47(4):253-71. PubMed ID: 6446594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Test-dependent antinociceptive effect of spinal serotonin release induced by intrathecal p-chloroamphetamine in mice.
    Berge OG; Fasmer OB; Jørgensen HA; Hole K
    Acta Physiol Scand; 1985 Jan; 123(1):35-41. PubMed ID: 3155890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attenuation of morphine-induced analgesia by p-chlorophenylalanine and p-chloroamphetamine: test-dependent effects and evidence for brainstem 5-hydroxytryptamine involvement.
    Berge OG; Hole K; Ogren SO
    Brain Res; 1983 Jul; 271(1):51-64. PubMed ID: 6224533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation of avoidance acquisition in rats produced by P-chlorophenylalanine or P-chloroamphetamine.
    Vorhees CV
    Pharmacol Biochem Behav; 1979 Apr; 10(4):569-76. PubMed ID: 156926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term reduction of brain serotonin by p-chloroamphetamine: effects of inducers and inhibitors of drug metabolism.
    Steranka LR; Sanders-Bush E
    J Pharmacol Exp Ther; 1978 Aug; 206(2):460-7. PubMed ID: 682126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Active and passive avoidance following the administration of systemic DSP4, xylamine, or p-chloroamphetamine.
    Archer T; Jonsson G; Ross SB
    Behav Neural Biol; 1985 May; 43(3):238-49. PubMed ID: 3842248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective lesions of the bulbospinal serotonergic pathways reduce the analgesia induced by p-chloroamphetamine in the hot-plate test.
    Berge OG; Ogren SO
    Neurosci Lett; 1984 Jan; 44(1):25-9. PubMed ID: 6717848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-chloroamphetamine: behavioral effects of reduced cerebral serotonin in rats.
    Vorhees CV; Schaefer GJ; Barrett RJ
    Pharmacol Biochem Behav; 1975; 3(2):279-84. PubMed ID: 1144484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inhibition of the cage-leaving response--a model for studies of the serotonergic neurotransmission in the rat.
    Rényi L; Archer T; Minor BG; Tandberg B; Fredriksson A; Ross SB
    J Neural Transm; 1986; 65(3-4):193-210. PubMed ID: 3011984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.